Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Hempel

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Antimicrobial Agents and Chemotherapy|January 22, 2013
Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosisGudrun Würthwein, Oliver A Cornely, Mirjam N Trame, et al.
Clinical Pharmacokinetics|March 23, 2007
Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicityStefan Wilde, Alexander Jetter, Stephan Rietbrock, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 17, 2021
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing DataGudrun Würthwein, Claudia Lanvers-Kaminsky, Christian Siebel, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
Population pharmacokinetics of liposomal amphotericin B and caspofungin in allogeneic hematopoietic stem cell recipientsGudrun Würthwein, Charlotte Young, Claudia Lanvers-Kaminsky, et al.
Anesthesia and Analgesia|June 27, 2018
Treating Anemia in the Preanesthesia Assessment Clinic: Results of a Retrospective EvaluationInes Ellermann, Andreas Bueckmann, Maria Eveslage, et al.
BMC Pharmacology & Toxicology|May 30, 2020
Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedureChristian Siebel, Gudrun Würthwein, Claudia Lanvers-Kaminsky, et al.
Deutsches Arzteblatt International|February 24, 2022
Structured Delirium Management in the HospitalJulia Krämer, Katharina Nolte, Laura Zupanc, et al.
Haematologica|December 10, 2020
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemiaAlaeddin Khalil, Gudrun Würthwein, Jana Golitsch, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia-a report from the UKALL 2011 trialRosanna K Jackson, Martina Liebich, Philip Berry, et al.
Cancers|December 24, 2021
Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study ProtocolAnna M Mc Laughlin, Eduard Schmulenson, Olga Teplytska, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|January 22, 2013
Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosisGudrun Würthwein, Oliver A Cornely, Mirjam N Trame, et al.
Clinical Pharmacokinetics|March 23, 2007
Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicityStefan Wilde, Alexander Jetter, Stephan Rietbrock, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 17, 2021
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing DataGudrun Würthwein, Claudia Lanvers-Kaminsky, Christian Siebel, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
Population pharmacokinetics of liposomal amphotericin B and caspofungin in allogeneic hematopoietic stem cell recipientsGudrun Würthwein, Charlotte Young, Claudia Lanvers-Kaminsky, et al.
Anesthesia and Analgesia|June 27, 2018
Treating Anemia in the Preanesthesia Assessment Clinic: Results of a Retrospective EvaluationInes Ellermann, Andreas Bueckmann, Maria Eveslage, et al.
BMC Pharmacology & Toxicology|May 30, 2020
Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedureChristian Siebel, Gudrun Würthwein, Claudia Lanvers-Kaminsky, et al.
Deutsches Arzteblatt International|February 24, 2022
Structured Delirium Management in the HospitalJulia Krämer, Katharina Nolte, Laura Zupanc, et al.
Haematologica|December 10, 2020
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemiaAlaeddin Khalil, Gudrun Würthwein, Jana Golitsch, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia-a report from the UKALL 2011 trialRosanna K Jackson, Martina Liebich, Philip Berry, et al.
Cancers|December 24, 2021
Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study ProtocolAnna M Mc Laughlin, Eduard Schmulenson, Olga Teplytska, et al.
Pageof 13